Anika Therapeutics: A Recent Greenblatt Small Cap Biotech Pick
Intrepid Investor • Yesterday, 8:38 AM
- Greenblatt's Magic Formula based on ROIC and EBIT/EV can be used to build a diversified portfolio that outperforms.
- A Magic Formula screen for drug companies with market cap >$500M 2 years ago identified Exelixis, Momenta, Pozen, and Questcor.
- Anika was identified on a screen this week - this company looks like a bargain.